Evrysdi savings card: as little as $0 a month with commercial insurance

How to pay the least

Ask for the cash price

Evrysdi

We didn’t find one.

Ask your pharmacy for Evrysdi’s cash price, and one or two other pharmacies too.
Evrysdi’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Genentech Patient Foundation. Do not have insurance coverage for their Genentech medicine and their household makes less than $150,000 per year Or call (888) 941-3331.

See if you qualify

Compare every option

Brand nameEvrysdi

Authorized genericrisdiplam

Regular genericrisdiplam

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Evrysdi?

The original

–

Brand nameThe maker’s card

Evrysdi Co-pay Program

Savings card from Genentech

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a month

The card takes up to $25,000 a year off your co-pay.

Or call 1-866-422-2377.

In the maker’s words

“With the Evrysdi Co-pay Program, eligible patients with commercial insurance could pay as little as $0 per 30-day supply of Evrysdi.”

From the maker’s offer on evrysdi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Evrysdi itself, from the same company, sold without the brand name, and usually for less. For now Evrysdi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Spinal muscular atrophy (SMA)

What the FDA label says

EVRYSDI is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

Source: the FDA label for Evrysdi (Genentech, Inc.), September 23, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/evrysdi/